LYMPHOMA DIFFUSE LARGE B-CELL
Clinical trials for LYMPHOMA DIFFUSE LARGE B-CELL explained in plain language.
Never miss a new study
Get alerted when new LYMPHOMA DIFFUSE LARGE B-CELL trials appear
Sign up with your email to follow new studies for LYMPHOMA DIFFUSE LARGE B-CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Off-the-Shelf CAR-T therapy aims to outsmart relapsed blood cancers
Disease control Recruiting nowThis study tests a new CAR-T therapy made from donor cells, so it's ready to use without waiting. It targets two proteins on cancer cells to reduce relapse risk. About 178 adults with hard-to-treat B-cell cancers will receive one infusion after chemotherapy. The main goals are to…
Matched conditions: LYMPHOMA DIFFUSE LARGE B-CELL
Phase: PHASE1, PHASE2 • Sponsor: AvenCell Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 10:29 UTC
-
New hope for blood cancer patients: experimental drug enters human trials
Disease control Recruiting nowThis study is testing an experimental drug called LY4584180 in adults with certain blood cancers (like lymphoma) that have not improved after at least two prior treatments. The main goals are to check the drug's safety, how the body processes it, and whether it can shrink tumors.…
Matched conditions: LYMPHOMA DIFFUSE LARGE B-CELL
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 18, 2026 12:09 UTC